2017
DOI: 10.15406/acp.2017.02.00035
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Antinuclear Antibody (ANA) Profile in Diagnosis of Systemic Lupus Erythematosus

Abstract: by The American College of Rheumatology published in 1982 and revised in 1997. Diagnosis of SLE is made if a patient satisfied 4 of 11 the criteria. 5 The criteria are malar rash, discoid rash, photosensitivity, oral ulcers, nonerosive arthritis, pleuritis or pericarditis, renal disorder, neurologic disorder, hematologic disorder, immunologic disorder, positive antinuclear antibody. DiscussionThis autoimmune disease characterized by the aberrant production of a broad and heterogenous group of autoantibodies. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 4 publications
(1 reference statement)
0
1
0
Order By: Relevance
“…Anti-nuclear antibodies (ANAs) are considered to be the serological hallmark of SLE. [15] Our results support the prominent role that ANAs have in LN disease aetiology, with 94.74% (n=36/38) of the LN study population being positive for ANA, accounting for 85.71% (n=36/42) of the entire CKD population with positive ANA, but not histologically proven LN. This translates to approximately every 8 in 10 ANA-positive individuals with CKD having LN.…”
supporting
confidence: 81%
See 1 more Smart Citation
“…Anti-nuclear antibodies (ANAs) are considered to be the serological hallmark of SLE. [15] Our results support the prominent role that ANAs have in LN disease aetiology, with 94.74% (n=36/38) of the LN study population being positive for ANA, accounting for 85.71% (n=36/42) of the entire CKD population with positive ANA, but not histologically proven LN. This translates to approximately every 8 in 10 ANA-positive individuals with CKD having LN.…”
supporting
confidence: 81%
“…Anti-dsDNA and anti-Sm antibodies are considered to be highly specific markers for SLE and are predictors of high risk for developing LN in patients with SLE. [15] However, a different type of ANA, namely anti-ribonucleoprotein (anti-RNP) antibody, which is not specific to SLE according to the ACR criteria, [5] was present in more than half (71.43%, n=20/28) of the total LN cohort with positive ANA, indicating that it may potentially be more specific to LN in our population.…”
mentioning
confidence: 80%
“…Pathogenic role of ANA is represented by multiple mechanisms including organ damage by immune complexes deposition (Wijaya and Bahrun, 2017). [ 33 ]…”
Section: Discussionmentioning
confidence: 99%